Loading...
The P42 peptide and Peptide-based therapies for Huntington’s disease
Huntington’s disease (HD) is a progressive neurodegenerative hereditary disease clinically characterised by the presence of involuntary movements, behavioural problems and cognitive decline. The disease-onset is usually between 30 and 50 years of age. HD is a rare disorder affecting approximately 1....
Saved in:
| Published in: | Orphanet J Rare Dis |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4794846/ https://ncbi.nlm.nih.gov/pubmed/26984770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-016-0405-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|